Observational Study of Rebismart®2.0 + MSdialog™ in Subjects With Remitting Multiple Sclerosis (ADHERQOL)

NCT02394782 · clinicaltrials.gov ↗

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped lower than anticipated recruitment rate

Conditions

Multiple Sclerosis, Relapsing-remitting

Interventions

DEVICE: RebiSmart®2.0
DEVICE: MSdialog™

Sponsor

Merck KGaA, Darmstadt, Germany